Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Comment by Frogger2on Feb 17, 2015 12:15pm
165 Views
Post# 23435983

RE:RE:RE:RE:Handling of the news release

RE:RE:RE:RE:Handling of the news releaseSeriously people, take a deep breath and let this play out. My take is that there is a good plan in place and it does not include a sell out or partner unless there is an amazing deal on the table. I have included portions of the Feb 15 release below. “We will fully evaluate and negotiate the current offers to ensure that if we take the decision to partner MCNA or sell the company at this juncture, that such a decision will capture significant value for our investors.” The Company’s analysis of the full MME data set, including data related to market size (epidemiology), anticipated market access and pricing, has led to the announcement today that the previously reported internal peak market estimates for the U.S. of up to $200 million per year were conservative and have been updated to reflect peak market estimates for the U.S. of more than $400 million. The full results of this comprehensive analysis are being made available, under confidentiality agreements, to potential partners and investors. Telesta also announced today they have engaged Bristol Capital, an internationally focused Investor Relations firm, to lead the company’s efforts to communicate the company’s potential to a broader audience of potential investors, with a strong focus on U.S., European and Canadian institutional funds and brokers with an interest and focus on small cap Canadian growth stories.
<< Previous
Bullboard Posts
Next >>